IgA nephropathy surgery: Difference between revisions
No edit summary |
|||
Line 21: | Line 21: | ||
==Indications== | ==Indications== | ||
*The mainstay of treatment for IgA nephropathy is medical therapy. Surgery is usually reserved for patients with either:<ref name="pmid8325026">{{cite journal |vauthors=Béné MC, Hurault de Ligny B, Kessler M, Foliguet B, Faure GC |title=Tonsils in IgA nephropathy |journal=Contrib Nephrol |volume=104 |issue= |pages=153–61 |date=1993 |pmid=8325026 |doi= |url=}}</ref> | |||
**IgA nephropathy and recurrent infections | |||
*The mainstay of treatment for | |||
** | |||
==Surgery== | ==Surgery== |
Revision as of 22:30, 24 May 2018
IgA nephropathy Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
IgA nephropathy surgery On the Web |
American Roentgen Ray Society Images of IgA nephropathy surgery |
Risk calculators and risk factors for IgA nephropathy surgery |
Overview
Surgical intervention is not recommended for the management of [disease name].
OR
Surgery is not the first-line treatment option for patients with [disease name]. Surgery is usually reserved for patients with either [indication 1], [indication 2], and [indication 3]
OR
The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3].
OR
The feasibility of surgery depends on the stage of [malignancy] at diagnosis.
OR
Surgery is the mainstay of treatment for [disease or malignancy].
Indications
- The mainstay of treatment for IgA nephropathy is medical therapy. Surgery is usually reserved for patients with either:[1]
- IgA nephropathy and recurrent infections
Surgery
- The feasibility of surgery depends on the stage of [malignancy] at diagnosis.
OR
- Surgery is the mainstay of treatment for [disease or malignancy].